Effects of gabapentin on thermal sensitivity following spinal nerve ligation or spinal cord compression

Behavioural Pharmacology

Volumn 24, Issue 7, 2013, Pages 598-609

  Yezierski, Robert P ^a   Green, Megan ^a   Murphy, Karen ^a   Vierck, Charles J ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Gabapentin; Nerve injury; Neuropathic pain; Operant testing; Rat; Spinal cord injury; Thermal sensitivity

Indexed keywords

GABAPENTIN; 4 AMINOBUTYRIC ACID; AMINE; ANALGESIC AGENT; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEAT SENSITIVITY; NERVE LIGATION; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; RAT; SPINAL CORD COMPRESSION; SPINAL NERVE; THERMAL STIMULATION; ANIMAL; ANIMAL BEHAVIOR; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; ESCAPE BEHAVIOR; INJURIES; INSTRUMENTAL CONDITIONING; LONG EVANS RAT; MALE; NEURALGIA; TEMPERATURE;

AMINES; ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; CONDITIONING, OPERANT; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCAPE REACTION; GAMMA-AMINOBUTYRIC ACID; MALE; NEURALGIA; RATS; RATS, LONG-EVANS; SPINAL CORD COMPRESSION; SPINAL NERVES; TEMPERATURE;

EID: 84888292785     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e3283656d9b     Document Type: Article

References (79)

1. Abdi S, Lee DY, Chung JM (1998). The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in the rat model of neuropathic pain. Anesth Analg 87:1360-1366.
2. Attal N, Jazat F, Kayser V, Guilbaud G (1990). Further evidence for pain-related behaviors in a model of unilateral peripheral mononeuropathy. Pain 41: 235-251.
3. Baastrup C, Maersk-Moller CC, Nyengaard JR, Jensen TR, Finnerup NB (2010). Spinal-, brainstem-and cerebrally mediated responses at-and below-level of a spinal cord contusion in rats: evaluation of pain-like behavior. Pain 151:670-679.
4. Backonja M (2001). Anticonvulsants and antiarrhythmics in the treatment of neuropathic pain syndromes. In Hansson PT, Fields HL, Hill RG, Marchettini P, editors. Neuropathic pain: pathophysiology and treatment. Progress in pain research and management. Vol 21: Seattle: IASP Press. pp. 185-201.
5. Baron R (2009). Neuropathic pain: A clinical perspective. Handb Exp Pharmacol 194:3-30.
6. Bee LA, Dickenson AH (2008). Descending facilitation from the brainstem determines behavioural and neuronal hypersensitivity following nerve injury and efficacy of pregabalin. Pain 140:209-223.
7. Boyce S, Wyatt A, Webb JK, ODonnell R, Mason G, Rigby M, et al. (1999). Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localization of NR2B subunit in dodrsal horn. Neuropharmacology 38:611-623.
8. Brennan TJ, Vandermeulen EP, Gehart GF (1996). Characterization of a rat model of incisional pain. Pain 64:493-501.
9. Burgess SE, Gardell LR, Ossipov MH, Malan TP, Vanderah TW, Lai J, Porreca F (2002). Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain. J Neurosci 22:5129-5136.
10. Chapman V, Suzuki R, Chamarette HL, Rygh LJ, Dickenson AH (1998). Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain 75:261-272.
11. Cheng JK, Pan HL, Eisenach JC (2000). Antiallodynic effect of intrathecal gabapentin and its interaction with clonidine in a rat model of post-operative pain. Anesthesiology 92:1126-1131.
12. Cheng J-K, Chiou L-C (2006). Mechanisms of the antinociceptive action of gabapentin. J Pharmacol Sci 100:471-486.
13. Cho HS, Kim MH, Choi DH, Lee JL, Gwak MS, Hahm TS (2002). The effect of intrathecal gabapentin on mechanical and thermal hyperalgesia in neuropathic rats induced by spinal nerve ligation. J Korean Med Sci 17:225-229.
14. Cobos EJ, Ghasemlou N, Araldi D, Segal D, Duong K, Woolf CJ (2012). Inflammation-induced decrease in voluntary wheel running in mice: A nonreflexive test for evaluating inflammatory pain and analgesia. Pain 153:876-884.
15. Coderre TJ, Kumar N, Lefebvre CD, Yu JSC (2005). Evidence that gabapentin reduces neuropathic pain by inhibiting the spinal release of glutamate. J Neurochem 94:1131-1139.
16. Densmore VS, Kalous A, Keast JR, Osborne PB (2010). Above-level mechanical hyperalgesia in rats develops after incomplete spinal cord injury but not after cord transaction, and is reversed by amitriptyline, morphine and gabapentin. Pain 151:184-193.
17. Dickenson AH, Matthews EA, Suzuki R (2002). Neurobiology of neuropathic pain: mode of action of anticonvulsants. Eur J Pain 6:51-60.
18. Field MJ, McCleary S, Hughs J, Singh L (1999). Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanimcal allodynia induced by streptozocin in the rat. Pain 80:391-398.
19. Finnerup NB, Sindrup SH, Jensen TS (2007). Chronic neuropathic pain: mechanisms, drug targets and measurement. Fundam Clin Pharmacol 21:129-136.
20. Gardell LR, Vanderah TW, Gardell SE, Wang R, Ossipov MH, Lai J, Porreca F (2003). Enhanced evoked excitatory transmitter release in experimental neuropathy requires descending facilitation. J Neurosci 23:8370-8379.
21. Hama A, Sagen J (2007). Behavioral characterization and effect of clinical drugs in a rat model of pain following spinal cord compression. Brain Res 1185:117-128.
22. Hansson P (2003). Difficulties in stratifying neuropathic pain by mechanisms. Eur J Pain 7:353-357.
23. Hansson PT, Fields HL, Hill RG, Marchettini PNeuropathic pain: pathophysiology and treatment. Progress in pain research and management. Vol 21: Seattle: IASP Press.
24. Hulsebosch CE, Xu GY, Perez-Polo JR, Westlund KN, Taylor CP, McAdoo DJ (2000). Rodent model of chronic central pain after spinal cord contusion injury and effects of gabapentin. J Neurotrauma 17:1205-1217.
25. Hunter JC, Gogas KR, Hedley LR, Jacobson LO, Kassotakis L, Thompson J, Fontana DJ (1997). The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol 324:153-160.
26. Jin SX, Zhuang ZY,Woolf CJ, Ji RR (2003). p38 mitogen-activated protein kinase is activated after a spinal nerve ligation in spinal cord microglia and dorsal root ganglion neurons and contributes to the generation of neuropathic pain. J Neurosci 23:4017-4022.
27. Jones DL, Sorkin LS (1998). Systemic gabapentin and S(+)-3-isobutyl- gammaaminobutyric acid block secondary hyperalgesia. Brain Res 810:93-99.
28. Jun JH, Yaksh TL (1998). The effect of intrathecal gabapentin and 3-isobutyl gamma aminobutyric acid on the hyperalgesia observed after thermal injury in the rat. Anesth Analg 86:348-354.
29. Kaneko M, Mestre C, Sanchez EH, Hammond DL (2000). Interathecally administered gabapentin inhibits formalin-evoked nociception and the expression of fos-like immunoreactivity in the spinal cord of rat. J Pharmacol Exp Ther 292:743-751.
30. Kayser V, Christensen D (2000). Antinociceptive effect of systemic gabapentin in mononeuropathic rats, depends on stimulus characteristics and level of test integration. Pain 88:53-60.
31. Kim P, Haisa T, Kawamoto T, Kirino T, Wakai S (2004). Delayed myelopathy induced by chronic compression in the rat spinal cord. Ann Neurol 55: 503-511.
32. Kim PJ, Yoon YW, Chung JM (1997). Comparison of three rodent neuropathic pain models. Exp Brain Res 113:200-206.
33. Kim SH, Chung JM (1992). An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50:355-363.
34. King C, Rodgers J, Devine D, Vierck CJ, Yezierski R (2003). Differential effects of stress on escape versus reflex responses to nociceptive thermal stimuli in the rat. Brain Res 987:214-222.
35. King C, Devine D, Vierck C, Mauderli A, Yezierski R (2007). Opioid modulation of reflex versus operant responses following stress in the rat. Neuroscience 147:174-182.
36. Kiso T,Watabiki T, Tsukamoto M, Okabe M, Kagami M, Nishimura K, et al. (2008). Pharmacological characterization and gene expression of an L5/L6 spinal nerve ligation model for neuropathic pain in mice. Neuroscience 153:492-500.
37. Kukkar A, Bali A, Singh N, Jaggi AS (2013). Implications and mechanism of action of gabapentin in neuropathic pain. Arch Pharm Res 36:237-251.
38. LaBuda CJ, Little PJ (2005). Pharmacological evaluation of the selective spinal nerve ligation model of neuropathic pain in the rat. J Neurosci Methods 144:175-181.
39. Levendoglu F, Ogun CO, Ozerbil O, Ogun TC, Ugurlu H (2004). Gabapentin is a first line drug for the treatment of neuropathic pain in spinal cord injury. Spine 29:743-751.
40. Liao X-Z, Zhou M-T, Mao Y-F, Xu H, Chern H, Sun J-H, Xiong Y-C (2010). Analgesic effects of gabapentin on mechanical hypersensitivity in a rat model of chronic pancreatitis. Brain Res 1337:104-112.
41. Lu Y, Westlund KN (1999). Gabapentin attenuates nociceptive behaviors in an acute arthritis model in rats. J Pharmacol Exp Ther 290:214-219.
42. Mauderli AP, Acosta-Rua A, Vierck CJ (2000). An operant assay of thermal pain in conscious, unrestrained rats. J Neurosci Methods 97:19-29.
43. Moore RA, Wiffen PJ, Derry S, McQuay HJ (2011). Gabapentin for chronic neuropathic pain and fibromyalagia in adults. Cochrane Database Syst Rev 16:CD007938.
44. Munro G, Erichsen HK, Mirza NR (2007). Pharmacological comparison of anticonvulsant drugs in animal models of persistent pain and anxiety. Neuropharmacology 53:609-618.
45. Nicholson B (2000). Gapabentin use in neuropathic pain syndromes. Acta Neurol Scand 101:359-371.
46. Okun A, Liu P, Davis P, Ren J, Remeniuk B, Brion T, et al. (2012). Afferent drive elicits ongoing pain in a model of advanced osteoarthritis. Pain 153: 924-933.
47. Pan HL, Eisenach JC, Chen SR (1999). Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J Pharmacol Exp Ther 288:1026-1030.
48. Partridge BJ, Chaplan SR, Sakamoto E, Yaksh TL (1998). Characterization of the effects of gabapentin and 3-isobutyl-gama-aminobutyric acid on substance P-induced thermal algesia. Anesthesiology 88:196-205.
49. Rice AS, Maton S (2001). Gabapentin in postherpetic neuralgia: A randomized, double blind, placebo controlled study. Pain 94:215-224.
50. Roeska K, Doods H, Arndt K, Treede RD, Ceci A (2008). Anxiety-like behavior in rats with mononeuropathy is reduced by the analgesic drugs morphine and gabapentin. Pain 139:349-357.
51. Rose MA, Kam PC (2002). Gabapentin: pharmacology and its use in pain management. Anaesthesia 57:451-462.
52. Rowbotham MC, Narden N, Stacey B, Bernstein P, Magnus-Miller L (1998). Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA 280:1837-1842.
53. Saade NE, Jabbur SJ (2008). Nociceptive behavior in animal models for peripheral neuropathy: spinal and supraspinal mechanisms. Prog Neurobiol 86:22-47.
54. Seltzer Z, Dubner R, Shir Y (1990). A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43:201-218.
55. Shimoyama N, Shimoyama M, Davis AM, Inturrisi CE, Elliott KJ (1997). Spinal gabapentin is antinociceptive in the rat formalin test. Neurosci Lett 222:65-67.
56. Sills GJ (2006). The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 6:108-113.
57. Singh L, Field MJ, Ferris P, Hunter JC, Oles RJ, Williams RG, Woodruff GN (1996). The antiepileptic agent gabapentin (Neurotin) possesses anxiolyticlike and antinociceptive actions that are reversed by D-serine. Psychopharmacology (Berl) 127:1-9.
58. Suzuki R, Rahman W, Hunt SP, Dickenson AH (2004). Descending facilitatory control of mechanically evoked responses is enhanced in deep dorsal horn neurons following peripheral nerve injury. Brain Res 1019:68-76.
59. Stanfa LC, Singh L,Williams RG, Dickenson AH (1997). Gabapentin, ineffective in normal rats, markedly reduces c-fibre evoked responses after inflammation. Neuroreport 10:587-590.
60. Tai Q, Kirshblum S, Chen B, Millis S, Johnston M, DeLisa JA (2002). Gabapentin in the treatment of neuropathic pain after spinal cord injury: A prospective, randomized, double-blind, crossover trial. J Spinal Cord Med 25:100-105.
61. Tanabe M, Takasu K, Takeuchi Y, Ono H (2008). Pain relief by gabapentin and pregabalin via supraspinal mechanisms after peripheral nerve injury. J Neurosci Res 86:3258-3264.
62. Taylor CP, Gee NS, Su TZ, Kocsis JD, Welty DF, Brown JP, et al. (1998). A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 29:233-249.
63. To TP, Lim TC, Hill ST, Frauman AG, Cooper N, Kirsa SW, Brown DJ (2002). Gabapentin for neuropathic pain following spinal cord injury. Spinal Cord 40:282-285.
64. Todorovic SM, Rastogi AJ, Jevtovic-Todorovic V (2003). Potent analgesic effects of anticonvulsants on peripheral thermal nociception in rats. Br J Pharmacol 140:255-260.
65. Tzellow TG, Papazisis G, Amanti E, Kouvelas D (2008). Efficacy of pregabalin and gabapentin for neuropathic pain in spinal-cord injury: An evidence-based evaluation of the literature. Eur J Clin Pharmacol 64:851-858.
66. Vera-Portocarrero LP, Zhang ET, Ossipov NH, Xie JY, King T, Lai J, Porreca F (2006). Descending facilitation from the rostral ventromedial medulla maintains nerve injury-induced central sensitization. Neuroscience 140:1311-1320.
67. Vierck C, Acosta-Rua A, Nelligan R, Tester N, Mauderli A (2002). Low dose systemic morphine attenuates operant escape but facilitates innate reflex responses to thermal stimulation. J Pain 3:309-319.
68. Vierck CJ, Kline R, Wiley R (2003). Intrathecal substance P-saporin attenuates operant escape from nociceptive thermal stimuli. Neuroscience 119:223-232.
69. Vierck CJ, Kline RL III, Wiley RG (2004). Comparison of operant escape and innate reflex responses to nociceptive skin temperatures produced by heat and cold stimulation of rats. Behav Neurosci 118:627-635.
70. Vierck CJ, Acosta-Rua AJ, Johnson RD (2005). Bilateral chronic constriction of the sciatic nerve: A model of long-term cold hyperalgesia. J Pain 6:507-517.
71. Vierck CJ (2006). Animal models of pain. In: McMahon S, Koltzenburg M, editors. Wall and Melzacks textbook of pain. London: Elsevier Churchill Livingston. pp. 175-185.
72. Vierck CJ, Hansson PT, Yezierski RP (2008a). Clinical versus pre-clinical pain assessment: Are we measuring the same thing Pain 135:7-10.
73. Vierck CJ, Yezierski RP, Light AR (2008b). Long-lasting hyperalgesia and sympathetic dysregulation after formalin injection into the rat hind paw. Neuroscience 153:501-506.
74. Wallace VC, Segerdahl AR, Blackbeard J, Pheby T, Rice AS (2008). Anxiety-like behavior is attenuated by gabapentin, morphine and diazepam in a rodent model of HIV anti-retroviral-associated neuropathic pain. Neurosci Lett 448:153-156.
75. Woolf CJ, Shortland P, Coggeshall RE (1992). Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 355:75-78.
76. Woolf C, Mannion R (1999). Neuropathic pain: Aetiology, symptoms, mechanisms and management. Lancet 353:1959-1964.
77. Yezierski RP (2000). Pain following spinal cord injury: pathophysiology and central mechanisms. In Sandku hler J, Bromm B, Gebhart GF, editors. Nervous system plasticity and chronic pain. Vol 129: Amsterdam: Elsevier. pp. 429-449.
78. Yezierski RP, King C, Morgan D, Carter C, Vierck CJ (2010). Effects of age on thermal sensitivity. J Gerontol 65:353-362.
79. Zeilhofer HU, Zeilhofer UB (2008). Spinal dis-inhibition in inflammatory pain. Neurosci Lett 437:170-174.